
White Cross Pharmaceuticals Private Limited
About White Cross Pharmaceuticals Private Limited
Data last updated:
White Cross Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 03 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2009PTC062934.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Linus Trade Private Limited. It is led by directors including Satyanarayana Murthy Aila and Veera Venkata Lakshmi Pechetti.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 507 Vijeetha Rinda Meadows New Nagole Mohan Nagar, Hyderabad, Telangana, India – 500035.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
White Cross Pharmaceuticals has one previous CIN (Corporate Identification Number): U24233AP2009PTC062934. The current CIN is U24233TG2009PTC062934, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2009PTC062934 | Current |
| U24233AP2009PTC062934 | Previous |
Contact details
White Cross Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 507 Vijeetha Rinda Meadows New Nagole Mohan Nagar, Hyderabad, Telangana, India – 500035
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of White Cross Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of White Cross Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of White Cross Pharmaceuticals Private Limited, buy the company report.
Board of directors of White Cross Pharmaceuticals Private Limited
White Cross Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyanarayana Murthy Aila | Director | 01 Dec 2010 | 15 Years 11 Months | Current |
| Veera Venkata Lakshmi Pechetti Also directs: Nextware Solutions Private Limited | Director | 03 Mar 2009 | 17 Years 8 Months | Current |
| Ravi Kumar Gubbala | Director | 03 Mar 2009 | 17 Years 8 Months | Current |
Auditor
White Cross Pharmaceuticals Private Limited is audited by Kota and company for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kota and company | FY 2017 | 011982S |
Shareholding
The shareholding of White Cross Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of White Cross Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving White Cross Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for White Cross Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for White Cross Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
White Cross Pharmaceuticals Private Limited has 4 board changes on record since 2009: 3 appointments and 1 cessation. The latest: Guntupalli Usha Devi ceased to be Director on 28 May 2019.
Frequently asked questions
White Cross Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in wholesale, within the trading industry. It was incorporated on 03 March 2009 (17+ years old) and is registered under CIN U24233TG2009PTC062934.
White Cross Pharmaceuticals has 3 current directors:
- Satyanarayana Murthy Aila - Director
- Veera Venkata Lakshmi Pechetti - Director
- Ravi Kumar Gubbala - Director
The latest financial statements of White Cross Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of White Cross Pharmaceuticals is U24233TG2009PTC062934. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
White Cross Pharmaceuticals was incorporated on 03 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.
Guntupalli Usha Devi ceased to be Director on 28 May 2019. Satyanarayana Murthy Aila was appointed as Director on 01 Dec 2010. Ravi Kumar Gubbala was appointed as Director on 03 Mar 2009. White Cross Pharmaceuticals has 4 board changes on record in total.
The registered office of White Cross Pharmaceuticals is at Flat No. 507 Vijeetha Rinda Meadows New Nagole Mohan Nagar, Hyderabad, Telangana, India – 500035.
White Cross Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of White Cross Pharmaceuticals is compliant as of 11 September 2026. The company is actively filing with the Registrar of Companies.
Yes. White Cross Pharmaceuticals was formerly known as Linus Trade Private Limited.

